Congress Wealth Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,000
Closed -$13.4K 1107
2024
Q4
$13.4K Buy
+12,000
New +$10.2K ﹤0.01% 871
2024
Q1
Sell
-12,000
Closed -$16.1K 622
2023
Q4
$16.1K Buy
+12,000
New +$14.1K ﹤0.01% 605
2022
Q3
Sell
-12,000
Closed -$16K 561
2022
Q2
$16K Hold
12,000
﹤0.01% 549
2022
Q1
$25K Hold
12,000
﹤0.01% 591
2021
Q4
$45K Buy
+12,000
New +$51.6K ﹤0.01% 602

Other funds holding PGEN

Congress Wealth Management's PGEN Position: Q1 2025 in Review

Congress Wealth Management sold out of Precigen (PGEN) in Q1 2025, closing a stake of 12,000 shares — an estimated $13.4K sold.

Congress Wealth Management first reported a position in PGEN in Q4 2021 and held it in 5 quarters. The position peaked at $45K in Q4 2021. 138 funds tracked by Wall St. Rank hold PGEN as of Q1 2025.

  • Congress Wealth Management reported no remaining Precigen position as of Q1 2025 after selling out during the quarter.
  • Congress Wealth Management sold 12,000 Precigen shares in Q1 2025, an estimated $13.4K.
  • Congress Wealth Management first reported a position in Precigen in Q4 2021 and held it in 5 quarters.
  • Congress Wealth Management's Precigen position peaked at $45K in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q1 2025.

Based on Congress Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.